Prevalence of childhood exanthematic disease antibodies in paramedical students: Need of vaccination

Vaccine

Volumn 24, Issue 2, 2006, Pages 171-176

  Trevisan, Andrea ^a   Morandin, Marta ^a   Frasson, Clara ^a   Paruzzolo, Paolo ^a   Davanzo, Elisabetta ^a   Marco, Livio Di ^a   Fabrello, Andrea ^a   Borella Venturini, Matteo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Exanthematic diseases; Paramedical students; Vaccine

Indexed keywords

IMMUNOGLOBULIN G; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MUMPS VACCINE; RUBELLA VACCINE; VARICELLA ZOSTER VACCINE;

ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CHICKENPOX; COLLEGE STUDENT; CONTROLLED STUDY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MEASLES; MUMPS; PRIORITY JOURNAL; RASH; REVACCINATION; RUBELLA; SEROCONVERSION; SEROPREVALENCE; SEX DIFFERENCE; SEX RATIO;

ADULT; ANTIBODIES; CHILD; EXANTHEMA; FEMALE; HUMANS; MALE; SEROEPIDEMIOLOGIC STUDIES; STUDENTS, MEDICAL; VIRAL VACCINES;

EID: 28644450405     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.062     Document Type: Article

References (41)

1. Gallo G. Varicella: per non confondere le priorità. www.epicentro.iss.it/focus/varicella/varicella_gallo.asp.
2. Centers for Disease Control and Prevention. Immunization of health-care workers. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1997; 46 (No RR-18): 1-12.
3. Centers for Disease Control and Prevention. Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998; 47 (No RR-8): 10-20.
4. Centers for Disease Control and Prevention. Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999; 48 (No RR-6): 1-5.
5. J. Gallagher, B. Quaid, and B. Cryan Susceptibility to varicella zoster virus infection in health care workers Occup Med 46 4 1996 289 292
6. G. Vandersmissen, G. Moens, R. Vranckx, A. de Schryver, and P. Jacques Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study Occup Environ Med 57 9 2000 621 626
7. U. Fedeli, C. Zanetti, and B. Saia Susceptibility of healthcare workers to measles, mumps, rubella and varicella J Hosp Infect 51 2 2002 133 135
8. M. Almuneef, J. Dillon, M.F. Abbas, and Z. Memish Varicella zoster virus immunity in multinational health care workers of a Saudi Arabian hospital Am J Infect Control 31 6 2003 375 381
9. C.Y. Chong, S.H. Lim, W.Y.M. Ng, N. Tee, and R.V.T.P. Lin Varicella screening and vaccination for healthcare workers at KK women's and children's hospital Ann Acad Med Singapore 33 2 2004 243 247
10. S. Hatakeyama, K. Moriya, S. Itoyama, Y. Nukui, M. Uchida, and Y. Shintani Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan Infect Control Hosp Epidemiol 25 7 2004 591 594
11. B.D. Schoub, S. Johnson, J.M. McAnerney, and L. Borkon Susceptibility to poliomyelitis, measles, mumps and rubella in university students South Afr Med J 77 1 1990 18 20
12. K.L. Nichol, and R. Olson Medical students' exposure and immunity to vaccine-preventable diseases Arch Intern Med 153 16 1993 1913 1916
13. T. Tashiro, H. Urata, J. Okada, K. Iwanaga, M. Tokunaga, and T. Matsumoto Vaccination against rubella, measles, chickenpox, and mumps in nursing students Kansenshogaku Zasshi 78 5 2004 398 403 [in Japanese, abstract available in English]
14. A. Nardone, R.G. Pebody, S. van den Hof, D. Levy-Bruhl, A.M. Plesner, and M.C. Rota Sero-epidemiology of mumps in western Europe Epidemiol Infect 131 1 2003 691 701
15. P.K.S. Chan, C.Y. Li, J.S. Tam, and A.F. Cheng Rubella immune status among healthcare workers in the department of obstetrics and gynaecology of a regional hospital in Hong Kong: the need for a vaccination policy J Hosp Infect 42 3 1999 239 242
16. M. Ciofi degli Atti, A. Filia, M.G. Revello, W. Buffolano, and S. Salmaso Rubella control in Italy EuroSurveillance 9 4 2004 17 18
17. I. Davidkin, H. Peltola, and P. Leinikki Epidemiology of rubella in Finland EuroSurveillance 9 4 2004 11 12
18. T. Mazzulli, K.S. MacDonald, D. Kitching, M. Skulnick, D.E. Low, and R. Chua Evaluation of the automated vitek immunodiagnostic assay system (VIDAS) for the detection of measles (rubeola) IgG antibodies Clin Diagn Virol 3 3 1995 207 213
19. R.T. Chen, L.E. Markowitz, P. Albrecht, J.A. Stewart, L.M. Mofenson, and S.R. Preblud Measles antibody: reevaluation of protective titers J Infect Dis 162 5 1990 1036 1042
20. L.K. Ammari, L.M. Bell, and R.L. Hodinka Secondary measles vaccine failure in healthcare workers exposed to infected patients Infect Control Hosp Epidemiol 14 2 1993 81 86
21. B.H. Stover, G. Adams, C.A. Kuebler, K.M. Cost, and G.P. Rabalais Measles-mumps-rubella immunization of susceptible hospital employees during a community measles outbreak: cost-effectiveness and protective efficacy Infect Control Hosp Epidemiol 15 1 1994 18 21
22. M.E. Willy, D.E. Koziol, T. Fleisher, S. Koo, H. McFarland, and J. Schmitt Measles immunity in a population of healthcare workers Infect Control Hosp Epidemiol 15 1 1994 12 17
23. S. Salmaso, G. Gabutti, M.C. Rota, C. Giordano, C. Penna, and D. Mandolini Pattern of susceptibility to measles in Italy Bull World Health Org 78 8 2000 950 955
24. B. Borcic, R. Mazuran, and B. Kaic Immunity to measles in the Croatian population Eur J Epidemiol 18 11 2003 1079 1083
25. F. Averhoff, L. Linton, M.K. Peddecord, C. Edwards, W. Wang, and D. Fishbein A middle school immunization law rapidly and substantially increases immunization coverage among adolescents Am J Public Health 94 6 2004 978 984
26. A. Patja, I. Davidkin, T. Kurki, M.J. Kallio, M. Valle, and H. Peltola Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up Pediatr Infect Dis J 19 12 2000 1127 1134
27. A. Patja, S. Mäkinen-Kiljunen, I. Davidkin, M. Paunio, and H. Peltola Allergic reactions to measles-mumps-rubella vaccination Pediatrics 107 2 2001 e27
28. M. Virtanen, H. Peltola, M. Paunio, and O.P. Heinonen Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination Pediatrics 106 5 2000 e62
29. T. Ozaki, N. Nishimura, and Y. Kajita Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic Vaccine 18 22 2000 2375 2380
30. L. Saiman, P. LaRussa, S.P. Steinberg, J. Zhou, K. Baron, and S. Whittier Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers Infect Control Hosp Epidemiol 22 5 2001 279 283
31. K. Ampofo, L. Saiman, P. LaRussa, S. Steinberg, P. Annunziato, and A. Gershon Persistence of immunity to live attenuated varicella vaccine in healthy adults Clin Infect Dis 34 6 2002 774 779
32. S. Gatchalian, D. Leboulleux, E. Desauziers, N. Bermal, and C. Borja-Tabora Immunogenicity and safety of a varicella vaccine, OKAVAX™, and a trivalent measles, mumps and rubella vaccine, MMR-II, administered concomitantly in healthy Filipino children aged 12-24 months Southeast Asian J Trop Med Public Health 34 3 2003 589 597
33. S. Gatchalian, C. Tabora, N. Bermal, D. Leboulleux, and E. Desauziers Immunogenicity and safety of a varicella vaccine (OKAVAX™) and a trivalent measles, mumps, and rubella vaccine (TRIMOVAX™) administered concomitantly in healthy Filipino children 12-24 months old Am J Trop Med Hyg 70 3 2004 273 277
34. E. Da Silva Carvalho Vacina contra varicela J Pediatr (Rio J) 71 3 1995 129 131 [in Portuguese, abstract available in English]
35. Y.J. Lim, F.T. Chew, Tan AYS, and B.W. Lee Risk factors for breakthrough varicella in healthy children Arch Dis Child 79 6 1998 478 480
36. H.R. Shinefield, S.B. Black, B.O. Staehle, H. Matthews, T. Adelman, and K. Ensor Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children Pediatr Infect Dis J 21 6 2002 555 561
37. T. Nolan, P. McIntyre, D. Roberton, and D. Descamps Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine Vaccine 21 3-4 2002 281 289
38. B. Rentier, A.A. Gershon the Members of the Europe Working Group on Varicella (EuroVar) Consensus: varicella vaccination of healthy children. A challenge for Europe Pediatr Infect Dis J 23 5 2004 379 389
39. D.M. Weinstock, M. Rogers, S. Lim, J. Eagan, and K.A. Sepkowitz Seroconversion rates in healthcare workers using a latex agglutination assay after varicella virus vaccination Infect Control Hosp Epidemiol 20 7 1999 504 507
40. T.-F. Leung, C.-K. Li, E.C.W. Hung, P.K.S. Chan, C.-W. Mo, and R.P.O. Wong Immunogenicity of a two-dose regime of varicella vaccine in children with cancers Eur J Haematol 72 5 2004 353 357
41. A. Trevisan, M. Borella Venturini, P. Paruzzolo, and S. Maso Hepatitis B vaccination awareness and biological risk Med Lav 93 4 2002 318 321